HAPPYNEURON

Happyneuron specializes in screen-viewed therapeutic software for mental health and cognitive function. Their devices fall under the category of mental health/function therapeutic software, designed for cognitive training and psychiatric cognitive remediation. These digital solutions provide structured, interactive exercises to support cognitive enhancement and functional recovery, typically accessed via computer or tablet.

Happyneuron is based in France, which means its devices are subject to EU medical device regulations. The company’s products are registered in the EUDAMED database, the official EU system for tracking medical devices. While the country of origin influences regulatory requirements, individual devices must still meet the specific classification and compliance criteria set by EU and national authorities.

Happyneuron’s devices are listed in EUDAMED (the EU’s medical device registry) and the FDA’s Unique Device Identifier (UDI) system in the U.S. Inclusion in these databases ensures transparency and traceability, which are critical for regulatory oversight, market surveillance, and patient safety. For example, EUDAMED helps authorities verify compliance with EU MDR/AMDR requirements, while the FDA’s UDI system supports tracking and recall management in the U.S. market.

Happyneuron’s devices are classified as Class I and Class II medical devices. Classification determines the regulatory pathway and scrutiny level. For instance, Class II devices (like some cognitive remediation software) may require additional clinical evaluations or post-market surveillance due to their higher risk potential compared to Class I devices (e.g., low-risk cognitive training programs). The classification is based on factors like intended use, risk to the patient, and the device’s interaction with the body.